SynthesisFrontiers in cardiovascular medicine2024

Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systematic network meta-analysis.

Yuhua Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.